By Brian Moran, Vice President of Pharmacy at HealthTrust Performance Group
Biosimilars offer savings opportunities for hospitals, providers and patients that are often overlooked. However, taking advantage of biosimilars can involve hurdles that may seem daunting for administrators and pharmacy executives. The good news is that these hurdles can be overcome, and any additional effort will be vastly outweighed by the savings generated.
What Are Biosimilars?
Biosimilars approved by the FDA are